Clinical trial
The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom…
NCT00381758 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00381758 |
|---|---|
| Title | The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting |
| Official title | A Randomized, Double-Blind Comparison of the Time Course of Response to Two Extended-Release Oral Delivery Systems for Methylphenidate in Pediatric Patients With Attention Deficit Hyperactivity Disorder in an Analog Classroom Setting: The CoMACS Study |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Methylphenidate Extended Release Capsules |
| Enrollment | 184 |
| Start date | May 1, 2002 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Sep 28, 2006 |
| Last update posted | Mar 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: